Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Simplifying molecular subtypes of metastatic gastric cancer
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
8 Oct 2019
Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroe...
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
8 Oct 2019
Highlights from ESMO 2019
Prof Josep Tabernero - ESMO President
4 Oct 2019
SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer...
Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA
4 Oct 2019
Nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Prof Ahmed Kaseb - MD Anderson Cancer Center, Houston, USA
4 Oct 2019
Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC
Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain
4 Oct 2019
IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer
Dr Ramon Salazar - Catalan Institute of Oncology, Barcelona, Spain
4 Oct 2019
Blood first assay screening in patients with ALK positive NSCLC
Prof Shirish Gadgeel - University of Michigan, Ann Arbor, USA
4 Oct 2019
Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative ad...
Dr Véronique Diéras - Centre Eugène Marquis, Rennes, France
4 Oct 2019
CUPISCO: Identifying carcinoma of unknown primary patients according to ESMO gui...
Prof Jeffrey S. Ross - Albany Medical Center, Albany, USA
4 Oct 2019
CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line...
Dr Thomas Yau - The University of Hong Kong, Hong Kong
4 Oct 2019
Optimal timing of radiotherapy following radical prostatectomy
Prof Chris Parker - The Royal Marsden Hospital, London, UK
4 Oct 2019
